广告
加载中

净亏损5.87亿元 新氧集团发布2024全年财报

张从容 2025-04-02 14:36
张从容 2025/04/02 14:36

邦小白快读

EN
全文速览

新氧集团2024全年财报显示关键财务数据和业务变化。

1. 净亏损5.87亿元,为近4年最高,主要源于商誉减值5.4亿元,而2023年无此减值。

2. 总营收14.67亿元,同比收窄2.09%;毛利润8.99亿元,同比收窄5.72%;总营业费用15.24亿元,同比增长50.15%。

3. 业务转型初见成效:医疗美容服务营收1.69亿元,同比增长1206.14%;医疗产品和维护服务营收3.68亿元,同比增长10.33%;但信息、预订服务营收9.29亿元,同比收窄19.29%。

4. 毛利率对比:信息、预订服务72.80%,医疗产品50.22%,医疗美容服务仅22.26%,显示新业务增长快但利润低。

5. CEO金星表示2024年是转型关键年,聚焦轻医美连锁业务,全年连锁营收1.7亿元,增长1206%。

财报揭示消费趋势和品牌战略方向。

1. 消费趋势:医疗美容服务营收激增1206%,表明用户对轻医美需求旺盛,品牌可关注此增长点。

2. 品牌定价和价格竞争:医疗美容服务毛利率仅22.26%,远低于信息服务的72.80%,提示品牌需优化定价策略以提升利润。

3. 产品研发:业务转型聚焦轻医美连锁,反映产品研发向此倾斜,可借鉴新氧模式。

4. 用户行为观察:信息、预订服务营收收窄19.29%,显示用户偏好转向医疗美容,影响品牌渠道建设。

5. 品牌营销启示:新氧官方发布转型成效,强调连锁业务增长,品牌可学习其营销策略以捕捉新机会。

财报提供市场机会和风险提示。

1. 增长市场:医疗美容服务营收同比增1206%,机会巨大,可拓展此领域。

2. 风险提示:净亏损5.87亿元,营业费用增50.15%,商誉减值5.4亿元,提示财务风险需谨慎。

3. 可学习点:业务转型初见成效,聚焦轻医美连锁营收增1206%,卖家可借鉴此模式。

4. 最新商业模式:轻医美连锁发展,合作方式可能涉及平台招商,如新氧聚焦此业务。

5. 消费需求变化:信息、预订服务收窄19.29%,而医疗产品增10.33%,显示需求转向医疗相关服务,卖家可调整策略。

财报揭示产品需求和商业机会。

1. 产品生产需求:医疗产品和维护服务营收3.68亿元,增10.33%,显示稳定生产需求;医疗美容服务激增1206%,带来新生产机会。

2. 商业机会:轻医美连锁业务营收1.7亿元,增长1206%,工厂可探索此领域合作。

3. 推进数字化和电商启示:新氧作为电商平台转型成功,工厂可学习其数字化经验,如优化线上销售。

4. 设计需求:基于医疗美容服务增长,工厂需关注轻医美产品设计,以匹配市场变化。

财报显示行业趋势和客户痛点。

1. 行业发展趋势:医疗美容服务营收增1206%,行业向轻医美倾斜,服务商可提供相关解决方案。

2. 客户痛点:新氧净亏损5.87亿元,营业费用增50.15%,显示运营成本高和财务挑战,服务商需针对性解决。

3. 解决方案:业务转型聚焦轻医美初见成效,服务商可借鉴此模式,提供优化服务。

4. 新技术启示:虽未直接提及,但数字化推进隐含在电商转型中,服务商可探索技术应用。

财报反映平台运营和需求。

1. 平台最新做法:新氧聚焦轻医美连锁业务,营收增1206%,显示战略调整。

2. 商业对平台需求:医疗美容服务增长快,平台需满足此需求,如招商和合作。

3. 运营管理:营业费用增50.15%,销售费用减4.99%,研发费用减18.91%,提示需优化成本管理。

4. 风向规避:高亏损5.87亿元和商誉减值风险,平台应规避类似财务问题。

5. 平台招商机会:新业务增长提供招商潜力,平台可加强轻医美领域合作。

财报揭示产业动向和商业模式。

1. 产业新动向:业务转型至轻医美连锁,营收增1206%,显示行业重心转移。

2. 新问题:商誉减值5.4亿元导致高亏损,引发财务健康关注,需研究成因。

3. 商业模式:轻医美连锁模式发展,但毛利率仅22.26%,对比美丽田园集团52.30%,提示模式优化空间。

4. 政策法规启示:虽未直接提及,但财务风险如高费用增50.15%,可建议监管关注企业健康。

返回默认

声明:快读内容全程由AI生成,请注意甄别信息。如您发现问题,请发送邮件至 run@ebrun.com 。

我是 品牌商 卖家 工厂 服务商 平台商 研究者 帮我再读一遍。

Quick Summary

So-Young's 2024 full-year financial report reveals key financial data and business shifts.

1. The net loss reached RMB 587 million, the highest in nearly four years, primarily due to a RMB 540 million goodwill impairment, whereas there was no such impairment in 2023.

2. Total revenue was RMB 1.467 billion, narrowing by 2.09% year-over-year; gross profit was RMB 899 million, narrowing by 5.72% YoY; total operating expenses surged to RMB 1.524 billion, up 50.15% YoY.

3. Business transformation shows initial results: medical aesthetic service revenue grew 1,206.14% YoY to RMB 169 million; medical product and maintenance service revenue increased 10.33% YoY to RMB 368 million; however, information and reservation service revenue declined 19.29% YoY to RMB 929 million.

4. Gross margin comparisons: information and reservation services at 72.80%, medical products at 50.22%, and medical aesthetic services at only 22.26%, indicating rapid growth in new businesses but lower profitability.

5. CEO Jin Xing stated 2024 was a pivotal year for transformation, focusing on the light medical aesthetic chain business, with annual chain revenue reaching RMB 170 million, a 1,206% increase.

The financial report reveals consumer trends and strategic directions for brands.

1. Consumer trends: Medical aesthetic service revenue surged 1,206%, indicating strong user demand for light medical aesthetics, a key growth area for brands to focus on.

2. Brand pricing and competition: The gross margin for medical aesthetic services is only 22.26%, significantly lower than the 72.80% for information services, suggesting brands need to optimize pricing strategies to improve profitability.

3. Product R&D: The business transformation focuses on light medical aesthetic chains, reflecting a shift in product development; brands can learn from So-Young's model.

4. User behavior observation: Information and reservation service revenue declined 19.29%, showing a user preference shift toward medical aesthetics, impacting brand channel strategies.

5. Marketing insights: So-Young's official release highlights transformation results and chain business growth; brands can study its marketing approach to capture new opportunities.

The report provides market opportunities and risk warnings for sellers.

1. Growth market: Medical aesthetic service revenue increased 1,206% YoY, presenting significant opportunities for expansion in this sector.

2. Risk warnings: A net loss of RMB 587 million, a 50.15% increase in operating expenses, and a RMB 540 million goodwill impairment highlight financial risks requiring caution.

3. Key takeaways: The business transformation shows initial success, with light medical aesthetic chain revenue up 1,206%; sellers can adopt similar models.

4. Latest business model: The development of light medical aesthetic chains may involve platform partnerships, as seen with So-Young's focus on this area.

5. Shifting consumer demand: Information and reservation services declined 19.29%, while medical products grew 10.33%, indicating a shift toward medical-related services; sellers should adjust strategies accordingly.

The report indicates product demand and commercial opportunities for factories.

1. Production demand: Medical product and maintenance service revenue reached RMB 368 million, up 10.33%, showing stable demand; medical aesthetic services surged 1,206%, creating new production opportunities.

2. Commercial opportunities: Light medical aesthetic chain business revenue hit RMB 170 million, growing 1,206%; factories can explore partnerships in this field.

3. Digital and e-commerce insights: So-Young's successful transformation as an e-commerce platform offers lessons in digitalization, such as optimizing online sales.

4. Design needs: Based on the growth in medical aesthetic services, factories should focus on light medical aesthetic product design to align with market changes.

The report highlights industry trends and client pain points for service providers.

1. Industry trends: Medical aesthetic service revenue grew 1,206%, indicating a shift toward light medical aesthetics; service providers can offer relevant solutions.

2. Client pain points: So-Young's net loss of RMB 587 million and a 50.15% increase in operating expenses reveal high costs and financial challenges, requiring targeted solutions from providers.

3. Solutions: The successful business transformation focusing on light medical aesthetics offers a model for service providers to emulate and optimize their offerings.

4. Technology insights: Although not directly mentioned, digital advancement is implied in the e-commerce transformation; service providers can explore technological applications.

The report reflects platform operations and demand for marketplace operators.

1. Platform strategies: So-Young's focus on light medical aesthetic chains resulted in a 1,206% revenue increase, demonstrating strategic adjustments.

2. Commercial demands on platforms: Rapid growth in medical aesthetic services requires platforms to meet this demand through partnerships and merchant recruitment.

3. Operational management: Operating expenses rose 50.15%, while sales expenses fell 4.99% and R&D expenses decreased 18.91%, highlighting the need for cost optimization.

4. Risk avoidance: The high loss of RMB 587 million and goodwill impairment risks caution platforms to avoid similar financial issues.

5. Partnership opportunities: Growth in new businesses offers potential for merchant recruitment; platforms can enhance collaborations in the light medical aesthetics sector.

The report reveals industry movements and business models for researchers.

1. Industry shifts: The business transformation to light medical aesthetic chains, with revenue up 1,206%, indicates a shift in industry focus.

2. Emerging issues: A RMB 540 million goodwill impairment leading to high losses raises concerns about financial health, warranting research into causes.

3. Business models: The development of light medical aesthetic chains shows a gross margin of only 22.26%, compared to 52.30% for Meili Tianyuan Group, suggesting room for optimization.

4. Policy implications: Although not directly mentioned, financial risks like the 50.15% expense increase could prompt regulatory attention to corporate health.

Disclaimer: The "Quick Summary" content is entirely generated by AI. Please exercise discretion when interpreting the information. For issues or corrections, please email run@ebrun.com .

I am a Brand Seller Factory Service Provider Marketplace Seller Researcher Read it again.

【亿邦原创】3月28日,新氧发布2024年全年财报。2024年,新氧集团总营收14.67亿元,同比收窄2.09%;毛利润8.99亿元,同比收窄5.72%;净亏损5.87亿元,归属于新氧国际公司的净亏损5.9亿元。

值得注意的是,这是新氧集团近4年来净亏损最高的一年,或主要来源于商誉减值。2024年,新氧集团商誉减值5.4亿元,而2023年无商誉减值。总营业费用15.24亿元,同比增长50.15%。

其余营业费用变化不大:销售和市场费用4.94亿元,同比收窄-4.99%;一般与管理费用3.24亿元,同比增长11.46%;研发费用1.65亿元,同比收窄-18.91%。

总营业收入收窄2.09%,主要源于支柱业务——信息、预订服务和其他营业收入的收窄,该业务2024年营收9.29亿元,同比收窄19.29%,在总营收中占比63.37%。

其他两项业务营收均有所增长。医疗产品和维护服务的销售营业收入3.68亿元,同比增长10.33%;医疗美容服务营业收入1.69亿元,同比增长1206.14%。

新氧集团官方微信公众号发布图文称,集团业务转型初见成效,全年连锁业务营收1.7亿元,同比增长1206%。新氧集团董事长兼CEO金星表示,2024年对新氧来说是转型的关键一年,集团将战略重心聚焦于轻医美连锁业务的发展。

然而,相比于另两项业务,医疗美容服务的毛利率并不高:信息、预订服务和其他业务毛利率72.80%,医疗产品和维护服务毛利率50.22%,而医疗美容服务毛利率仅为22.26%。同时,美丽田园集团的美容保健和医疗美容的毛利率,分别为40.70%和52.30%。

亿邦持续追踪报道该情报,如想了解更多与本文相关信息,请扫码关注作者微信。

文章来源:亿邦动力

广告
微信
朋友圈

这么好看,分享一下?

朋友圈 分享

APP内打开

+1
+1
微信好友 朋友圈 新浪微博 QQ空间
关闭
收藏成功
发送
/140 0